Cyclin H predicts the poor prognosis and promotes the proliferation of ovarian cancer

被引:0
作者
Chen Peng
Yansong Yang
Li Ji
Panpan Yang
Xiaoqing Yang
Yuquan Zhang
机构
[1] Affiliated Hospital of Nantong University,Department of Gynecology and Obstetrics
[2] Affiliated Cancer Hospital of Nantong University,Department of Radiology
[3] Clinical Medicine of Nantong University,undefined
来源
Cancer Cell International | / 20卷
关键词
Cyclin H; CDK2; Ovarian cancer; Cell cycle;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 144 条
[1]  
Herzog TJ(2006)Ovarian cancer: a focus on management of recurrent disease Nat Clin Pract Oncol 3 604-611
[2]  
Pothuri B(2017)Epidemiology of epithelial ovarian cancer Best Pract Res Clin Obstet Gynaecol. 41 3-14
[3]  
Webb PM(2017)Epidemiology of ovarian cancer: a review Cancer Biol Med. 14 9-32
[4]  
Jordan SJ(2018)Ovarian cancer: a heterogeneous disease Pathobiology 85 41-49
[5]  
Reid BM(2016)Diagnosis and management of ovarian cancer Am Fam Physician 93 937-944
[6]  
Permuth JB(2019)Ovarian cancer: an integrated review Semin Oncol Nurs 35 151-156
[7]  
Sellers TA(2011)Hallmarks of cancer: the next generation Cell 144 646-674
[8]  
Kossai M(2012)Cyclins and cell cycle control in cancer and disease Genes Cancer. 3 649-657
[9]  
Leary A(2015)Cyclin-Dependent Kinase Inhibitors as Anticancer Therapeutics Mol Pharmacol 88 846-852
[10]  
Scoazec JY(2017)Cell cycle regulation and anticancer drug discovery Cancer Biol Med. 14 348-362